is grateful to University of Exeter and BBSRC funded ERA-IB grant BB/L002035/1
Labs are not required to start or to continue treatment at Willow
Expert guidance based on real science and your unique biology
Most acute side effects do not manifest at short duration
We serve patients from Anaheim CA, Buena Park CA, La Palma CA, Cerritos CA, Cypress CA, Stanton CA, Garden Grove CA, Fullerton CA, Placentia CA, and Olive CA
Why dual-pathway targeting is more effective Single pathway limitations: GLP-1 alone eventually plateaus Body compensates over time Weight loss slows after 6-12 months Some people don't respond optimally Dual pathway advantages: Harder for body to compensate Multiple redundant systems targeted Sustained weight loss longer Better for non-responders to single therapy Mechanistic synergy: Amylin + GLP-1 naturally work together Both released after meals normally Physiologic combination Not forcing unnatural state Clinical implications: Patients who plateau on semaglutide benefit from adding cagrilintide Initial combination produces maximum results May prevent or delay weight regain Better long-term outcomes Cagrilintide and semaglutide dosing protocols Proper dosing ensures maximum efficacy with manageable side effects